Congress must update FDA’s ability to regulate diagnostic tests and cosmetics
VSongress is considering two measures that modernize the tools the Food and Drug Administration uses to oversee two areas of its broad portfolio: diagnostic tests and cosmetics. Although the stakes are different for each of these industries, the basic premise underlying these measures is the same. The FDA is currently working from an outdated regulatory …
Congress must update FDA’s ability to regulate diagnostic tests and cosmetics Read More »
